Loading clinical trials...
Loading clinical trials...
Long Term Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Post-Refractive Corneal Ectasia
The purpose of this research study is to evaluate the long tern safety and effectiveness of cross-linking in eyes with keratoconus and ectasia.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
No
Barnet Dulaney Perkins Eye Center
Phoenix, Arizona, United States
Woolfson Eye Institute
Atlanta, Georgia, United States
Massachusetts Eye And Ear Infirmary
Boston, Massachusetts, United States
Minnesota Eye Consultants
Bloomington, Minnesota, United States
Laser and Corneal Surgery Assoc. PC
New York, New York, United States
Mt Sinai Hospital
New York, New York, United States
Pamel Vision & Laser Group
New York, New York, United States
Cleveland Clinic-Cole Eye Institute
Cleveland, Ohio, United States
ReVision Advanced Laser Eye Center
Columbus, Ohio, United States
OSU Department of Ophthalomogy
Columbus, Ohio, United States
Start Date
December 1, 2010
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
June 29, 2022
500
ACTUAL participants
Riboflavin
DRUG
VEGA UV-A Illumination System
DEVICE
Lead Sponsor
Topcon Medical Systems, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions